Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Oct. 29, 2017	Oct. 30, 2016		Nov. 01, 2015
Cash flows from operating activities:
Net income	$ 21,289	$ 55,676	[1],[2]	$ 56,859
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property, plant and equipment	81,699	77,613		75,684
Amortization of intangible assets	4,874	5,228		6,729
Gains on sale of investments	0	(8,940)		0
Share-based compensation	3,627	3,827		3,689
Deferred income taxes	1,633	(3,816)		3,401
Changes in assets, liabilities, and other:
Accounts receivable	(9,625)	18,807		(21,815)
Inventories	(602)	2,268		(2,893)
Other current assets	1,127	7,936		(2,557)
Accounts payable, accrued liabilities, and other	(7,189)	(36,462)		14,098
Net cash provided by operating activities	96,833	122,137		133,195
Cash flows from investing activities:
Purchases of property, plant and equipment	(91,965)	(50,147)		(104,033)
Acquisition of business	(5,400)	0		0
Proceeds from sales of investments	167	101,853		0
Purchases of intangible assets	(834)	(13)		(771)
Other	(34)	597		499
Net cash (used in) provided by investing activities	(98,066)	52,290		(104,305)
Cash flows from financing activities:
Repayments of long-term borrowings	(5,428)	(57,609)		(9,571)
Dividends paid to noncontrolling interests	(8,298)	(11,890)		0
Proceeds from share-based arrangements	2,830	3,463		2,651
Return of capital to noncontrolling interests	0	(966)		0
Other	(32)	(20)		(179)
Net cash used in financing activities	(10,928)	(67,022)		(7,099)
Effects of exchange rate changes on cash and cash equivalents	6,108	802		(8,853)
Net (decrease) increase in cash and cash equivalents	(6,053)	108,207		12,938
Cash and cash equivalents at beginning of year	314,074	205,867		192,929
Cash and cash equivalents at end of year	308,021	314,074		205,867
Supplemental disclosure of non-cash information:
Accrual for property, plant and equipment purchased during year	2,767	7,866		25,858
Conversion of debt to common stock	$ 0	$ 7,439		$ 0

[1] Includes $8.8 million gain on sale of investment in a foreign entity.

[2] Includes tax benefits in Taiwan of $4.8 million primarily related to the recognition of prior period tax benefits and other tax positions no longer deemed necessary.